BackgroundAlthough many tools for the assessment of prostate cancer risk have been published, most are designed to predict only biochemical recurrence, usually after a single specified treatment. We assessed the accuracy of the Cancer of the Prostate Risk Assessment (CAPRA) score, which was validated previously to predict pathological and biochemical outcomes after radical prostatectomy, to predict metastases, prostate cancer-specific mortality, and all-cause mortality.MethodsWe studied 10 627 men with clinically localized prostate cancer in the Cancer of the Prostate Strategic Urologic Research Endeavor registry, who underwent primary radical prostatectomy, radiation therapy (external beam or interstitial), androgen deprivation monotherapy...
Background: The natural history of prostate cancer is highly variable and difficult to predict accur...
ObjectivesTo assess the ability of preoperative prostate-specific antigen level, Gleason score and s...
OBJECTIVES: To assess the ability of preoperative prostate-specific antigen level, Gleason score and...
BackgroundThe University of California, San Francisco, Cancer of the Prostate Risk Assessment Postsu...
BackgroundThe University of California, San Francisco (UCSF) Cancer of the Prostate Risk Assessment ...
PurposeMultivariate prognostic instruments aim to predict risk of recurrence among patients with loc...
BackgroundThe authors previously developed and validated the Cancer of the Prostate Risk Assessment ...
Abstract Background The Cancer of the Prostate Risk Assessment (CAPRA) score was designed and valida...
Background: The Cancer of the Prostate Risk Assessment Post‐Surgical (CAPRA‐S) score is a simple pos...
Background Risk prediction models that incorporate biomarkers and clinicopathologic variables may be...
BackgroundRisk prediction models that incorporate biomarkers and clinicopathologic variables may be ...
For men with low-stage prostate cancer (PCa) managed with active surveillance (AS), clinical thresho...
PurposeTwo methods widely used to predict the risk of treatment failure after radical prostatectomy ...
Objectives: To assess the ability of preoperative prostate-specific antigen level, Gleason score and...
Despite the key importance of magnetic resonance imaging (MRI) parameters, risk classification syste...
Background: The natural history of prostate cancer is highly variable and difficult to predict accur...
ObjectivesTo assess the ability of preoperative prostate-specific antigen level, Gleason score and s...
OBJECTIVES: To assess the ability of preoperative prostate-specific antigen level, Gleason score and...
BackgroundThe University of California, San Francisco, Cancer of the Prostate Risk Assessment Postsu...
BackgroundThe University of California, San Francisco (UCSF) Cancer of the Prostate Risk Assessment ...
PurposeMultivariate prognostic instruments aim to predict risk of recurrence among patients with loc...
BackgroundThe authors previously developed and validated the Cancer of the Prostate Risk Assessment ...
Abstract Background The Cancer of the Prostate Risk Assessment (CAPRA) score was designed and valida...
Background: The Cancer of the Prostate Risk Assessment Post‐Surgical (CAPRA‐S) score is a simple pos...
Background Risk prediction models that incorporate biomarkers and clinicopathologic variables may be...
BackgroundRisk prediction models that incorporate biomarkers and clinicopathologic variables may be ...
For men with low-stage prostate cancer (PCa) managed with active surveillance (AS), clinical thresho...
PurposeTwo methods widely used to predict the risk of treatment failure after radical prostatectomy ...
Objectives: To assess the ability of preoperative prostate-specific antigen level, Gleason score and...
Despite the key importance of magnetic resonance imaging (MRI) parameters, risk classification syste...
Background: The natural history of prostate cancer is highly variable and difficult to predict accur...
ObjectivesTo assess the ability of preoperative prostate-specific antigen level, Gleason score and s...
OBJECTIVES: To assess the ability of preoperative prostate-specific antigen level, Gleason score and...